Wasatch Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$719M Buy
7,960,735
+757,801
+11% +$64.2M 4.71% 1
2026
Q1
$602M Buy
7,202,934
+613,288
+9% +$50.3M 4% 1
2025
Q4
$604M Buy
6,589,646
+281,971
+4% +$27M 3.59% 1
2025
Q3
$598M Buy
6,307,675
+206,611
+3% +$19.4M 3.22% 3
2025
Q2
$639M Sell
6,101,064
-1,132,972
-16% -$107M 3.35% 1
2025
Q1
$639M Sell
7,234,036
-279,709
-4% -$28.7M 3.57% 1
2024
Q4
$721M Sell
7,513,745
-245,145
-3% -$22.8M 3.57% 2
2024
Q3
$635M Buy
7,758,890
+483,269
+7% +$37.3M 3.11% 2
2024
Q2
$627M Sell
7,275,621
-133,459
-2% -$10.8M 3.35% 1
2024
Q1
$605M Buy
7,409,080
+569,249
+8% +$44.4M 3.16% 2
2023
Q4
$453M Sell
6,839,831
-427,944
-6% -$29.7M 2.5% 4
2023
Q3
$531M Buy
7,267,775
+139,453
+2% +$9.42M 3.35% 2
2023
Q2
$450M Sell
7,128,322
-584,267
-8% -$33.9M 2.72% 3
2023
Q1
$453M Buy
7,712,589
+1,980,668
+35% +$120M 2.82% 2
2022
Q4
$353M Buy
5,731,921
+5,859
+0.1% +$394K 2.38% 4
2022
Q3
$385M Sell
5,726,062
-902,689
-14% -$57.1M 2.67% 4
2022
Q2
$407M Sell
6,628,751
-1,010,184
-13% -$64.7M 2.57% 3
2022
Q1
$515M Buy
7,638,935
+244,868
+3% +$13.2M 2.54% 4
2021
Q4
$327M Buy
7,394,067
+1,197,807
+19% +$69.8M 1.33% 18
2021
Q3
$401M Buy
6,196,260
+364,908
+6% +$25.3M 1.63% 11
2021
Q2
$469M Buy
5,831,352
+197,412
+4% +$15M 1.91% 7
2021
Q1
$383M Buy
5,633,940
+314,928
+6% +$24.7M 1.72% 9
2020
Q4
$371M Buy
5,319,012
+1,347,888
+34% +$83.8M 1.82% 12
2020
Q3
$204M Buy
3,971,124
+780,916
+24% +$42.9M 1.3% 20
2020
Q2
$187M Buy
3,190,208
+492,095
+18% +$27.2M 1.35% 20
2020
Q1
$136M Buy
2,698,113
+508,358
+23% +$33.8M 1.42% 22
2019
Q4
$162M Buy
2,189,755
+337,736
+18% +$21.1M 1.33% 20
2019
Q3
$106M Sell
1,852,019
-35,525
-2% -$2.36M 1.01% 40
2019
Q2
$123M Sell
1,887,544
-151,385
-7% -$10.5M 1.2% 27
2019
Q1
$151M Buy
2,038,929
+376,461
+23% +$26.5M 1.64% 15
2018
Q4
$99.2M Buy
1,662,468
+83,388
+5% +$6.72M 1.32% 23
2018
Q3
$149M Sell
1,579,080
-218,119
-12% -$18.8M 1.7% 15
2018
Q2
$135M Sell
1,797,199
-342,331
-16% -$24.6M 1.62% 18
2018
Q1
$130M Sell
2,139,530
-153,750
-7% -$8.32M 1.67% 17
2017
Q4
$107M Sell
2,293,280
-126,229
-5% -$6.25M 1.42% 19
2017
Q3
$122M Sell
2,419,509
-22,671
-0.9% -$1.06M 1.66% 13
2017
Q2
$122M Buy
2,442,180
+52,885
+2% +$2.47M 1.7% 13
2017
Q1
$101M Sell
2,389,295
-27,173
-1% -$1.2M 1.5% 16
2016
Q4
$97.9M Buy
2,416,468
+178,306
+8% +$6.89M 1.48% 16
2016
Q3
$84.7M Buy
2,238,162
+72,807
+3% +$2.31M 1.26% 19
2016
Q2
$65.8M Buy
2,165,355
+44,184
+2% +$1.16M 1.01% 27
2016
Q1
$51.8M Buy
2,121,171
+962,507
+83% +$20.6M 0.79% 41
2015
Q4
$29M Sell
1,158,664
-9,741
-0.8% -$299K 0.4% 77
2015
Q3
$34.5M Sell
1,168,405
-30,575
-3% -$961K 0.46% 76
2015
Q2
$38.4M Sell
1,198,980
-14,561
-1% -$391K 0.42% 85
2015
Q1
$30.3M Buy
1,213,541
+1,163,061
+2,304% +$25.2M 0.31% 104
2014
Q4
$1.28M Sell
50,480
-35
-0.1% -$759 0.01% 339
2014
Q3
$925K Buy
+50,515
New +$970K 0.01% 365

Other funds holding HQY

Wasatch Advisors's HQY Position: Q2 2026 in Review

Wasatch Advisors increased its HealthEquity (HQY) stake by 11% in Q2 2026, buying an estimated $64.2M and bringing the position to 7,960,735 shares worth $719M. The position accounts for 4.71% of the portfolio, ranked #1.

Wasatch Advisors first reported a position in HQY in Q3 2014 and has held it in 48 quarters since. The position peaked at $721M in Q4 2024. 116 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Wasatch Advisors held 7,960,735 shares of HealthEquity worth $719M as of Q2 2026.
  • Wasatch Advisors bought 757,801 HealthEquity shares in Q2 2026, an estimated $64.2M.
  • HealthEquity made up 4.71% of Wasatch Advisors's portfolio in Q2 2026, its #1 holding.
  • Wasatch Advisors first reported a position in HealthEquity in Q3 2014 and has held it in 48 quarters since.
  • Wasatch Advisors's HealthEquity position peaked at $721M in Q4 2024.
  • 116 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.